The development of polyanhydrides for drug delivery applications
- PMID: 1350734
- DOI: 10.1163/156856292x00402
The development of polyanhydrides for drug delivery applications
Abstract
This paper reviews the development of the polyanhydrides as bioerodible polymers for drug delivery applications. The topics include design and synthesis of the polymer, physical properties, techniques to fabricate the polymer into drug delivery devices, evaluation of biocompatibility, and example applications of the polyanhydrides. Discussion of the interrelationship between the physical-chemical properties of the polyanhydrides, fabrication methods, and drug release rates is included. One section is devoted to a case study to provide a historical perspective of the development a polyanhydride-based drug delivery treatment from the conception of the idea to the final stages of human clinical trials. This section includes an outline of the extensive in vitro and in vivo testing that is necessary for development of a new material for biomedical applications.
Similar articles
-
Bioerodible polyanhydrides for antibiotic drug delivery: in vivo osteomyelitis treatment in a rat model system.J Orthop Res. 1993 Mar;11(2):256-62. doi: 10.1002/jor.1100110213. J Orthop Res. 1993. PMID: 8483038
-
[The synthesis of polyanhydrides and its application in biomedical field].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003 Mar;20(1):135-8. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003. PMID: 12744184 Review. Chinese.
-
Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors.Pharm Res. 1999 May;16(5):762-5. doi: 10.1023/a:1011995728760. Pharm Res. 1999. PMID: 10350022 No abstract available.
-
Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.Anticancer Res. 2005 Nov-Dec;25(6B):3825-31. Anticancer Res. 2005. PMID: 16312042 Free PMC article.
-
Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas.Recent Results Cancer Res. 1994;135:149-54. doi: 10.1007/978-3-642-85039-4_15. Recent Results Cancer Res. 1994. PMID: 8047689 Review. No abstract available.
Cited by
-
Pharmacokinetics of the carmustine implant.Clin Pharmacokinet. 2002;41(6):403-19. doi: 10.2165/00003088-200241060-00002. Clin Pharmacokinet. 2002. PMID: 12074689 Review.
-
Attachment of an aminoglycoside, amikacin, to implantable collagen for local delivery in wounds.Antimicrob Agents Chemother. 1993 Sep;37(9):1890-5. doi: 10.1128/AAC.37.9.1890. Antimicrob Agents Chemother. 1993. PMID: 8239602 Free PMC article.
-
Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases.PLoS One. 2011 Mar 3;6(3):e17642. doi: 10.1371/journal.pone.0017642. PLoS One. 2011. PMID: 21408610 Free PMC article.
-
Cardiovascular stents: overview, evolution, and next generation.Prog Biomater. 2018 Sep;7(3):175-205. doi: 10.1007/s40204-018-0097-y. Epub 2018 Sep 10. Prog Biomater. 2018. PMID: 30203125 Free PMC article. Review.
-
Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus.Angew Chem Int Ed Engl. 2011 Mar 7;50(11):2597-600. doi: 10.1002/anie.201006849. Epub 2011 Feb 18. Angew Chem Int Ed Engl. 2011. PMID: 21370345 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources